Memorial Sloan Kettering Cancer Center Updates in Thrombosis & Hemostasis 2024
Include: 17 videos + 17 pdfs, size: 3.33 GB
Target Audience: hematologists/oncologists, intensivists, emergency medicine practitioners, primary care physicians
Information:
Date & Location Sunday, October 27, 2024, 9:00 AM – 3:00 PM, Zuckerman Research Center, New York, NY
This symposium aims to deliver the latest updates in benign hematology, with a special emphasis on venous thromboembolism and anticoagulation. The 2024 program will focus on three main areas:
- Current challenges in Venous Thromboembolism (VTE)
- Novel anticoagulants
- Thrombotic complications of clonal disorders
Key topics will include thrombophilia testing, the role of interventional radiology in VTE management, and challenging scenarios such as chronic thromboembolic pulmonary hypertension (CTEPH), refractory thrombosis, and splanchnic thrombosis. Additionally, faculty will review the reversal of direct oral anticoagulants, novel factor XI inhibitors, and unique challenges in the management of thrombosis and clonal disorders (e.g., PNH and myeloproliferative neoplasm). Ample time will be allocated for Q&A and discussions with the faculty.
The target audience includes general medicine practitioners, hematologists/oncologists, intensivists, emergency medicine practitioners, primary care physicians, residents, fellows, advanced practice providers, and other healthcare professionals involved in the management and treatment of thrombotic and bleeding disorders.
- Provide guidance and updates on management of challenging thrombotic conditions including indications for thrombophilia testing, role of interventional radiology, management of refractory thrombosis, PNH, and anticoagulation in brain tumors.
- Summarize recent data on management of anticoagulant related hemorrhage and discuss emerging FXI inhibitors and their potential for improved safety profiles.
- Recognize the challenges in managing thrombo-hemorrhagic risks in patients with myeloproliferative neoplasms.
Topics:
- Anticoagulation in Thrombocytopenic Patients.mp4
- Anticoagulation in Thrombocytopenic Patients.pdf
- Approach to Anticoagulation in Brain Tumors.mp4
- Approach to Anticoagulation in Brain Tumors.pdf
- BenignHeme2024_Brochure.pdf
- Bleeding with Direct Oral Anticoagulants.mp4
- Bleeding with Direct Oral Anticoagulants.pdf
- Factor XI Inhibitors- The Holy Grail of Anticoagulants.mp4
- Factor XI Inhibitors- The Holy Grail of Anticoagulants.pdf
- Hematologic Complications of Immunotherapy.mp4
- Hematologic Complications of Immunotherapy.pdf
- Indications and Safety of Combined Antiplatelet and Anticoagulant Therapy.mp4
- Indications and Safety of Combined Antiplatelet and Anticoagulant Therapy.pdf
- Ins and Outs of Chronic Thromboembolic Pulmonary Hypertension.mp4
- Ins and Outs of Chronic Thromboembolic Pulmonary Hypertension.pdf
- Myeloproliferative Disease and Thrombosis.mp4
- Myeloproliferative Disease and Thrombosis.pdf
- Patient Perspective – Living with Venous Thromboembolism.mp4
- Patient Perspective – Living with Venous Thromboembolism.pdf
- Peri-Operative Management of Myeloproliferative Neoplasms.mp4
- Peri-Operative Management of Myeloproliferative Neoplasms.pdf
- Role of Interventional Radiology in Managing Venous Thromboembolism.mp4
- Role of Interventional Radiology in Managing Venous Thromboembolism.pdf
- ROUNDTABLE DISCUSSION – Myeloproliferative Neoplasms and Thrombosis.mp4
- Testing for Thrombophilia on Anticoagulants.mp4
- Testing for Thrombophilia on Anticoagulants.pdf
- The Challenge of Refractory Thrombosis.mp4
- The Challenge of Refractory Thrombosis.pdf
- Thrombophilia Testing – Who, When, and Why.mp4
- Thrombophilia Testing – Who, When, and Why.pdf
- Thrombosis and Breast Cancer Therapy.mp4
- Thrombosis and Breast Cancer Therapy.pdf
- Thrombosis and Paroxysmal Nocturnal Hemoglobinuria.mp4
- Thrombosis and Paroxysmal Nocturnal Hemoglobinuria.pdf